Gijbels Eva, Vinken Mathieu
Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium.
Methods Mol Biol. 2019;1981:1-14. doi: 10.1007/978-1-4939-9420-5_1.
Cholestasis can be defined as any situation of impaired bile secretion with concomitant accumulation of bile acids in the liver or in the systemic circulation. A variety of factors may evoke cholestasis, including genetic disorders, metabolic pathologies, infectious diseases, immunogenic stimuli, and drugs. Drug-induced cholestasis is a mechanistically complex process. At least three triggering factors of drug-induced cholestasis have been described, including effects on drug transporters, various hepatocellular changes, and altered bile canaliculi dynamics. These stimuli induce two cellular responses, each typified by a number of key events, namely a deteriorative response activated by bile acid accumulation and an adaptive response aimed at decreasing the uptake and increasing the export of bile acids into and from the liver, respectively. The mechanistic scenario of drug-induced cholestasis is described in this chapter.
胆汁淤积可定义为胆汁分泌受损且胆汁酸在肝脏或体循环中蓄积的任何情况。多种因素可引发胆汁淤积,包括遗传疾病、代谢性疾病、传染病、免疫原性刺激和药物。药物性胆汁淤积是一个机制复杂的过程。至少已描述了药物性胆汁淤积的三种触发因素,包括对药物转运体的影响、各种肝细胞变化以及胆小管动力学改变。这些刺激引发两种细胞反应,每种反应以一些关键事件为特征,即由胆汁酸蓄积激活的恶化反应和分别旨在减少胆汁酸向肝脏内摄取并增加胆汁酸从肝脏输出的适应性反应。本章将描述药物性胆汁淤积的机制情况。